SXTC — CHINA SXT PHARMACEUTICALS IN
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 5 SEC-registered investment managers reported holding SXTC (CHINA SXT PHARMACEUTICALS IN) in their latest 13F filings, with a combined reported value of $62.87K across 20.88K shares. That is +197100.0% by share count (+1.97K shares) versus the previous quarter, while reported value moved +296700.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 4 opened new positions, 1 added to existing stakes, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of CHINA SXT PHARMACEUTICALS IN (SXTC) include Citadel Advisors, Marex Group Ltd, Invesco Ltd, ranked by reported 13F value among the 26 institutional holders on this page.
SXTC is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 5 | 20.88K | $62.87K | +197100.0% |
| Q2 2026 | 2 | 3 | $6 | +50.0% |
| Q1 2026 | 3 | 78.17K | $131.33K | -99.5% |
| Q4 2025 | 8 | 327.57K | $524.04K | +35.7% |
| Q3 2025 | 10 | 310.84K | $490.57K | -58.3% |
| Q2 2025 | 3 | 76.72K | $132.56K | +1087.8% |
| Q1 2025 | 1 | 5.27K | $13.15K | +65775.0% |
| Q4 2024 | 2 | 10.01K | $5.08K | -46.4% |
Over the 8 quarters shown, institutional share counts increased 109% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (+65775.0%).
Top Institutional Holders (Q3 2026) — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 18.21K | $54.81K | 0.00% | New | |
| 1.97K | $5.94K | 0.00% | Add | |
| 695 | $2.11K | 0.00% | New | |
| 4 | $11 | 0.00% | New | |
| 1 | $3 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2 | $4 | 0.00% | Add | |
| 1 | $2 | 0.00% | Hold |
Q1 2026 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 78.17K | $131.33K | 1.53% | New | |
| 1 | $2 | 0.00% | Reduce | |
| 1 | $2 | 0.00% | New |
Q4 2025 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 150.58K | $240.92K | 0.00% | Add | |
| 85.33K | $136.53K | 0.00% | Reduce | |
| 53.67K | $85.87K | 0.00% | Hold | |
| 22.77K | $36.44K | 0.00% | New | |
| 12.36K | $20.00K | 0.00% | Reduce | |
| 1.83K | $2.92K | 0.00% | Reduce | |
| 818 | $1.00K | 0.00% | New | |
| 222 | $356 | 0.00% | Add |
Q3 2025 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 89.66K | $140.77K | 0.00% | New | |
| 53.67K | $85.34K | 0.00% | New | |
| 48.76K | $77.53K | 0.00% | New | |
| 44.50K | $69.86K | 0.00% | New | |
| 28.98K | $46.00K | 0.00% | Add | |
| 26.75K | $42.00K | 0.00% | New | |
| 15.45K | $24.25K | 0.00% | New | |
| 2.88K | $4.52K | 0.00% | Add | |
| 100 | $157 | 0.00% | Reduce | |
| 89 | $142 | 0.00% | New |
Q2 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 62.60K | $108.30K | 0.00% | Add | |
| 13.97K | $24.00K | 0.00% | New | |
| 151 | $261 | 0.00% | New |
New Positions (Q3 2026)
- JANE STREET GROUP, LLC 18.21K sh · $54.81K
- Robinhood Markets, Inc. 695 sh · $2.11K
- JPMorgan Chase & Co 4 sh · $11
- Citigroup Inc 1 sh · $3
Fully Exited (vs previous quarter)
- Caitong International Asset Management Co., Ltd sold 2 sh · $4
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 18.21K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 1.97K | 1 | 1 | 222 | 100 | 62.60K | 5.27K | 8 | 8.68K | 12.57K | 8 | 6.41K | 29.87K | — | 17.95K | 10.62K | 7.72K | — | 51.81K | 18.61K |
| Robinhood Markets, Inc. | 695 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 4 | — | — | — | — | — | — | — | 376 | — | — | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 34.20K | — |
| Citadel Advisors | — | — | — | 150.58K | 48.76K | — | — | — | — | 16.11K | — | — | 191.34K | — | 24.41K | — | — | — | 266.28K | — |
| Marex Group Ltd | — | — | — | — | — | — | — | — | — | — | — | 41.29K | — | — | — | — | — | — | — | — |
| Invesco Ltd | — | — | — | 85.33K | 89.66K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SABBY MANAGEMENT, LLC | — | — | 78.17K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | — | — | — | — | 44.50K | — | — | — | — | — | — | — | — | 10.54K | 34.50K | — | 21.57K | 29.47K | 451.50K | 21.40K |
| Geode Capital Management | — | — | — | 53.67K | 53.67K | — | — | — | — | — | — | — | — | — | — | — | — | — | 26.64K | 26.64K |
| Virtu Financial LLC | — | — | — | 12.36K | 28.98K | 13.97K | — | — | — | 31.61K | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | — | — | — | — | 26.75K | — | — | — | — | — | — | — | 48.51K | — | — | — | — | — | — | — |
| XTX Topco Ltd | — | — | — | 22.77K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TWO SIGMA SECURITIES, LLC | — | — | — | — | 15.45K | — | — | — | — | — | — | — | 49.97K | — | — | — | — | — | — | — |
| BANK OF MONTREAL /CAN/ | — | — | — | — | — | — | — | 10.00K | 10.00K | 10.00K | — | — | — | — | — | — | — | — | — | — |
| GSA CAPITAL PARTNERS LLP | — | — | — | — | — | — | — | — | 12.30K | — | — | — | — | — | — | — | — | — | — | — |
| Baader Bank Aktiengesellschaft | — | — | — | — | — | — | — | — | 15.16K | — | — | — | 12.92K | — | — | — | — | — | — | — |
| LEVEL FOUR ADVISORY SERVICES, LLC | — | — | — | — | — | — | — | — | — | — | — | — | 42.77K | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | — | — | — | 1.83K | 2.88K | 151 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold SXTC?
As of 2026-Q3, 5 institutional funds reported holding SXTC (CHINA SXT PHARMACEUTICALS IN) in SEC 13F filings, with a combined reported value of $62.87K.
How many shares of SXTC do institutions own?
13F filers reported 20.88K shares of SXTC, worth $62.87K in aggregate at the end of 2026-Q3.
Is institutional ownership of SXTC rising or falling?
Share counts moved +197100.0% versus the prior quarter — accumulation.
Who are the top institutional holders of SXTC?
The largest 13F holders are Citadel Advisors, Marex Group Ltd, Invesco Ltd, SABBY MANAGEMENT, LLC, Geode Capital Management; the top 25 are ranked at the top of this page.
Who are the major shareholders of CHINA SXT PHARMACEUTICALS IN?
The major shareholders of CHINA SXT PHARMACEUTICALS IN (SXTC) by reported 13F value are Citadel Advisors, Marex Group Ltd, Invesco Ltd, SABBY MANAGEMENT, LLC, Geode Capital Management, among 26 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.